Ben Flaum

Ben Flaum has an extensive work background in the fields of finance, strategy, and research. Ben currently serves as the Associate Director of Strategic Finance at Boundless Bio. Prior to this, they worked at EQRx, where they focused on corporate and portfolio strategy. Ben also had an important role at TG Therapeutics, Inc., where they contributed to strategy and operations. Ben gained valuable experience as an Investment Analyst in Biotechnology at Opus Point Partners and previously served as a Research Intern at the same company. Additionally, Ben has contributed to the Vanderbilt University community, working as a Researcher and Cancer Lab Research Assistant at the Vanderbilt University Medical Center.

Ben Flaum attended Vanderbilt University, where they earned a Bachelor of Arts (B.A.) degree in Economics and Spanish.